These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. LNA-mediated microRNA silencing in non-human primates. Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051 [TBL] [Abstract][Full Text] [Related]
9. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach. Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574 [TBL] [Abstract][Full Text] [Related]
11. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma. Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer. Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MS. Franzoni S; Vezzelli A; Turtoro A; Solazzo L; Greco A; Tassone P; Di Martino MT; Breda M J Pharm Biomed Anal; 2018 Feb; 150():300-307. PubMed ID: 29268195 [TBL] [Abstract][Full Text] [Related]
15. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo. Torres A; Kozak J; Korolczuk A; Rycak D; Wdowiak P; Maciejewski R; Torres K Oncotarget; 2016 Nov; 7(45):73651-73663. PubMed ID: 27655663 [TBL] [Abstract][Full Text] [Related]
16. PEI-complexed LNA antiseeds as miRNA inhibitors. Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918 [TBL] [Abstract][Full Text] [Related]
17. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430 [TBL] [Abstract][Full Text] [Related]
18. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma. Najafi Z; Sharifi M; Javadi G J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771 [TBL] [Abstract][Full Text] [Related]
20. Comparison of different chemically modified inhibitors of miR-199b in vivo. Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]